Table 1.
Characteristic | SLNM groupn = 48 | nLNM groupn = 254 | Statistical significancea |
---|---|---|---|
Age, years | 46.2 ± 8.7 | 44.9 ± 7.4 | NS |
FIGO stage | P = 0.001 | ||
IA2 | 0(0.0) | 34 (13.4) | |
IB | 14 (29.2) | 111 (43.7) | |
IIA | 34 (70.8) | 109 (42.9) | |
Tumour size, cm | NS | ||
≥4 | 24 (50.0) | 132 (52.0) | |
<4 | 24 (50.0) | 122 (48.0) | |
Tumour grade | P = 0.035 | ||
Well differentiated | 2 (4.2) | 32 (12.6) | |
Moderately differentiated | 6 (12.5) | 58 (22.8) | |
Poorly differentiated | 40 (83.3) | 164 (64.6) | |
Depth of tumour invasion | P < 0.001 | ||
T1 | 8 (16.7) | 134 (52.8) | |
T2 | 30 (62.5) | 110 (43.3) | |
T3 | 10 (20.8) | 10 (3.9) | |
Pathological cell type | NS | ||
Squamous cell carcinoma | 40 (83.3) | 234 (92.1) | |
Adenocarcinoma | 6 (12.5) | 16 (6.3) | |
Adenosquamous | 2 (4.2) | 4 (1.6) | |
Uterine body involvement | P = 0.001 | ||
Yes | 8 (16.7) | 10 (3.9) | |
No | 40 (83.3) | 244 (96.1) | |
Parametrial involvement | P < 0.001 | ||
Yes | 10 (20.8) | 12 (4.7) | |
No | 38 (79.2) | 242 (95.3) | |
Number of dissected lymph nodes | 21.7 ± 6.8 | 21.2 ± 8.1 | NS |
Lymphovascular invasion | P < 0.001 | ||
Positive | 24 (50.0) | 36 (14.2) | |
Negative | 24 (50.0) | 218 (85.8) | |
Ovarian shift | NS | ||
Yes | 6 (12.5) | 56 (22.0) | |
No | 42 (87.5) | 198 (78.0) |
Data presented as mean ± SD or n of patients (%).
aThe two groups were compared using Student’s t-test for continuous variables and χ2-test for categorical variables.
FIGO, International Federation of Gynecology and Obstetrics; T1, invasive <1/2 muscle layer; T2, invasive ≥1/2 muscle layer; T3, invasive cervical internal surface; NS, no significant between-group difference (P ≥0.05).